Sevelamer Carbonate Patent Expiration
Sevelamer Carbonate is Used for managing high levels of phosphate in the blood, often in patients with chronic kidney disease. It was first introduced by Sanofi Genzyme
Sevelamer Carbonate Patents
Given below is the list of patents protecting Sevelamer Carbonate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Renvela | US9095509 | Sachet formulation for amine polymers | Dec 06, 2030 | Genzyme |
| Renvela | US7985418 | Aliphatic amine polymer salts for tableting | Oct 27, 2025 | Sanofi |
| Renvela | US5667775 | Phosphate-binding polymers for oral administration |
Sep 16, 2014
(Expired) | Genzyme |
| Renvela | US5667775 | Phosphate-binding polymers for oral administration |
Sep 16, 2014
(Expired) | Sanofi |
| Renvela | US5496545 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renvela | US5496545 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Sanofi |
| Renvela | US6509013 | Method of making phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renvela | US6509013 | Method of making phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Sanofi |
| Renvela | US6858203 | Method of making phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renvela | US6858203 | Method of making phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Sanofi |
| Renvela | US7014846 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renvela | US7014846 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Sanofi |
| Renvela | US7459151 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renvela | US7459151 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Sanofi |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sevelamer Carbonate's patents.
Latest Legal Activities on Sevelamer Carbonate's Patents
Given below is the list recent legal activities going on the following patents of Sevelamer Carbonate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Jan, 2023 | US9095509 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 11 Jan, 2023 | US7985418 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 May, 2020 | US7459151 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 24 Jan, 2019 | US9095509 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Jan, 2019 | US7985418 |
| Patent Issue Date Used in PTA Calculation Critical | 04 Aug, 2015 | US9095509 |
| Recordation of Patent Grant Mailed Critical | 04 Aug, 2015 | US9095509 |
| Issue Notification Mailed Critical | 15 Jul, 2015 | US9095509 |
| Application Is Considered Ready for Issue Critical | 07 Jul, 2015 | US9095509 |
| Dispatch to FDC | 07 Jul, 2015 | US9095509 |
Sevelamer Carbonate's Family Patents
Explore Our Curated Drug Screens
Sevelamer Carbonate Generic API Manufacturers
Several generic applications have been filed for Sevelamer Carbonate. The first generic version for Sevelamer Carbonate was by Aurobindo Pharma Ltd and was approved on Jun 13, 2017. And the latest generic version is by Torrent Pharmaceuticals Ltd and was approved on Feb 27, 2025.
Given below is the list of companies who have filed for Sevelamer Carbonate generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Nov 28, 2017 |
2. ARTHUR GRP
Arthur Group Llc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Arthur Grp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Mar 20, 2018 |
3. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.4GM/PACKET | for suspension | Prescription | ORAL | AB | Jun 13, 2017 |
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | Jun 13, 2017 |
| 800MG | tablet | Prescription | ORAL | AB | Jul 17, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
4. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | May 17, 2021 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Discontinued | ORAL | N/A | Jan 14, 2021 |
| 2.4GM/PACKET | for suspension | Prescription | ORAL | AB | Mar 2, 2023 |
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | Mar 2, 2023 |
6. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Sep 29, 2017 |
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | Oct 25, 2018 |
| 2.4GM/PACKET | for suspension | Prescription | ORAL | AB | Oct 25, 2018 |
7. IMPAX
Impax Laboratories Llc has filed for 2 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Impax.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.4GM/PACKET | for suspension | Prescription | ORAL | AB | Nov 20, 2020 |
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | Nov 20, 2020 |
Manufacturing Plant Locations New
Impax's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Impax as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
8. IMPAX LABS INC
Impax Laboratories Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Discontinued | ORAL | N/A | Oct 23, 2017 |
9. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Oct 26, 2017 |
| 800MG/PACKET | for suspension | Discontinued | ORAL | N/A | Jul 12, 2024 |
| 2.4GM/PACKET | for suspension | Discontinued | ORAL | N/A | Jul 12, 2024 |
10. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG/PACKET | for suspension | Discontinued | ORAL | N/A | Dec 23, 2021 |
| 2.4GM/PACKET | for suspension | Discontinued | ORAL | N/A | Dec 23, 2021 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
11. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Apr 19, 2023 |
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | Apr 25, 2024 |
| 2.4GM/PACKET | for suspension | Prescription | ORAL | AB | Apr 25, 2024 |
12. MICRO LABS
Micro Labs Ltd has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Feb 7, 2022 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
13. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Nov 29, 2018 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
14. SHANDONG XINHUA
Shandong Xinhua Pharmaceutical Co Ltd has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Shandong Xinhua.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Oct 24, 2024 |
Manufacturing Plant Locations New
Shandong Xinhua's manufacturing plants are situated in 2 countries - China, United States. Given below are the details of these plant locations as well as the firm names of Shandong Xinhua as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| China |
| |||||||
| United States |
| |||||||
15. SINOTHERAPEUTICS INC
Sinotherapeutics Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Sinotherapeutics Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Discontinued | ORAL | N/A | Apr 9, 2020 |
Manufacturing Plant Locations New
Sinotherapeutics Inc's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Sinotherapeutics Inc as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
16. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | May 9, 2024 |
| 2.4GM/PACKET | for suspension | Prescription | ORAL | AB | Sep 8, 2023 |
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | Sep 8, 2023 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
17. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG/PACKET | for suspension | Prescription | ORAL | AB | Feb 27, 2025 |
| 2.4GM/PACKET | for suspension | Prescription | ORAL | AB | Feb 27, 2025 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
18. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Aug 11, 2020 |